Related Experiment Video

Updated: Apr 15, 2026

Isolated Pancreatic Islet Treatment and Apoptosis Measurement
09:36

Isolated Pancreatic Islet Treatment and Apoptosis Measurement

Published on: May 2, 2025

1.1K

Interferon-γ Decreases Nuclear Localization of Pdx-1 and Triggers β-Cell Dysfunction in Chronic Pancreatitis

Pavan Kumar Pondugala1, M Sasikala1, Venkat Rao Guduru2

  • 11 Asian Healthcare Foundation , Somajiguda, Hyderabad, India .

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|April 4, 2015
PubMed

Insights

Interferon-gamma (IFN-γ) impairs insulin gene expression in chronic pancreatitis (CP) by reducing Pdx-1 nuclear localization in beta cells. Epigallocatechin-3-gallate (EGCG) can restore this critical transcription factor.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Gastroenterology

Background:

  • Interferon-gamma (IFN-γ) is implicated in beta-cell dysfunction in chronic pancreatitis (CP).
  • The precise mechanisms by which IFN-γ affects beta cells in CP remain unclear.
  • Understanding these mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of IFN-γ in subverting insulin gene expression in chronic pancreatitis.
  • To determine the effect of IFN-γ on the nuclear localization of pancreatic and duodenal homeobox transcription factor (Pdx-1) in beta cells.

Main Methods:

  • Analysis of pancreatic tissues from control and CP patients for Pdx-1 nuclear localization.
  • Immunofluorescence and western blot analysis of isolated normal pancreatic islets.
  • Examination of the effects of IFN-γ, interleukin-10, and epigallocatechin-3-gallate (EGCG) on Pdx-1 nuclear localization.

Main Results:

  • Reduced nuclear localization of Pdx-1 was observed in islets of both diabetic and nondiabetic CP patients compared to controls.
  • Exposure of normal islets to IFN-γ significantly decreased Pdx-1 nuclear localization.
  • Pretreatment with EGCG successfully restored Pdx-1 nuclear localization in normal islets.

Conclusions:

  • IFN-γ contributes to beta-cell dysfunction in chronic pancreatitis by decreasing the nuclear localization of Pdx-1.
  • This mechanism involves the suppression of insulin gene expression.
  • EGCG shows potential in mitigating IFN-γ-induced beta-cell dysfunction.

More Related Videos

Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay08:40

Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay

Published on: May 2, 2019

6.4K
Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation07:44

Surgical Injury to the Mouse Pancreas through Ligation of the Pancreatic Duct as a Model for Endocrine and Exocrine Reprogramming and Proliferation

Published on: August 7, 2015

17.2K

Related Concept Videos

Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
928
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
3.2K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.6K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
17.4K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
9.0K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
532